Limbic, a NYC- and London, UK-based clinical mental health AI technology company, raised $14M in funding.
The round was led by Khosla Ventures with participation from Gaingels and Illusian.
The company intends to use the funds to expand the availability of its clinical mental health AI to U.S. health providers.
Led by CEO Dr. Ross Harper, Limbic is a clinical mental health AI company offering a care companion that supports users between therapy sessions. A chatbot interface powered by a clinical AI brain guides patients through a selection of 100 themed activities and educational materials, providing mental health support with clinical rigor on an on-demand basis.
The company says it has already helped over 260,000 NHS patients enter care, releasing over 50,000 clinical hours for NHS services and saving nearly 5 to 10 times the economic cost per additional user recovery. They have also increased the diversity of patients accessing mental health care.
FinSMEs
06/03/2024